Jul 1, 2009 | MediLexicon
Pari LC Plus And Proneb Ultra Used In Two Perforomist Studies On Improving Copd Therapies
Main Category: Respiratory / Asthma Also Included In: Medical Devices / Diagnostics In two recent COPD studies sponsored by DEY LP, PARI's LC Plus nebulizer and PRONEB compressors were used to show that nebulized formoterol fumarate improves pulmonary function.
Novartis' investigational COPD treatment may improve lung function
BASEL,A Switzerland Early results of a phase 3 trial have shown that an investigational treatment for chronic obstructive pulmonary disease can improve lung function within five minutes of the first dose.
Perforomist Inhalation Solution Data in Patients With Moderate to...
Data from two presentations highlighting the use of Perforomist Inhalation Solution in moderate to severe chronic obstructive pulmonary disease patients were featured today at the International Conference of the American Thoracic Society in San Diego.
Perforomist Inhalation Solution data to be presented at American Thoracic Society conference
Dey, L.P., a subsidiary of Mylan Inc. , announced today that data from two presentations highlighting the use of Perforomist Inhalation Solution will be featured in poster format at the International Conference of the American Thoracic Society on May 19, 2009 in San Diego.
Also on Topix